sábado, 14 de noviembre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 4, 2025

Earnings live: Ulta stock pops, HPE falls with guidance in focus, UiPath stock skyrockets

View original at finance.yahoo.com
Earnings live: Ulta stock pops, HPE falls with guidance in focus, UiPath stock skyrockets The third quarter earnings season is winding down, and only a handful of major companies have yet to report results…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Companies that miss earnings decreased by 5% on average during same period, well below five-year average decrease of 2.6%

    80% confidence
  • Q3 was an exceptional quarter with existing customers expanding and strong net-new customer additions

    80% confidence
  • What's worked for growth is expansion of the idea of what value looks like, with attention to items above $5 at $7, $10, $15

    80% confidence
  • These are the strongest quarterly results in Credo's history, reflecting the continued build-out of the world's largest AI training and inference clusters

    80% confidence
  • The Street is underestimating the growth potential for CrowdStrike as a beneficiary of the AI Revolution

    80% confidence
  • Companies that beat earnings saw 0.4% average stock increase in four-day period, less than five-year average of 0.9%

    80% confidence
  • Five Below has seen nice traffic growth and growth in both new customers and retention

    80% confidence
  • The Celestial AI acquisition further strengthens Marvell's position at the forefront of one of the fastest-growing opportunities in AI datacenter infrastructure

    80% confidence
  • Enterprises want AI that can work within their secure data environments without compromise, and this partnership brings Claude into Snowflake where data already lives

    80% confidence
  • The consumer and competitive environment has grown notably tougher for food retailers like Kroger

    80% confidence
  • Many consumers' wallets are pressured and they are seeking value during the holiday season

    80% confidence
  • Ulta is confident in their holiday plans and teams are ready to drive excitement and deliver for guests

    80% confidence
  • Strong momentum has continued into Q4, including an excellent start to the holiday season with a record-breaking Thanksgiving weekend

    80% confidence
  • Q3 sales were the strongest in 13 quarters, reflecting the acceleration of Bold New Chapter strategy and demonstrating that changes are resonating with customers

    80% confidence
  • AI clusters are now measured in hundreds of thousands and soon millions of GPUs, pushing every aspect of interconnect

    80% confidence
  • Analysts are expecting a 13.4% jump in earnings per share during Q3 2025, marking the fourth straight quarter of double-digit earnings growth

    80% confidence
  • All consumers are seeking value, and marrying value-seeking behavior with convenience and discovery is where Dollar Tree thrives

    80% confidence
  • 3 million more households are now part of Dollar Tree's customer base compared to last year, with high-income consumers making up the majority of new customers

    80% confidence
  • Sentiment toward food retailers has soured over the past few months, including for Kroger

    80% confidence

Data points we hold from this source

Snowflake Inc. · loss per share-0.87 USD
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,577 documentos fuente archivados
Consulta estos datos → isubstrate.com
Earnings live: Ulta stock pops, HPE falls with guidance in focus, UiPath stock skyrockets — Source | Via News | es.VIA.NEWS